Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,981 | -31,155 | -11,899 | -43,820 | -37,630 |
| Depreciation Amortization | 23,776 | 8,909 | 4,261 | 19,378 | 24,804 |
| Income taxes - deferred | -1,110 | -246 | -133 | -3,736 | -3,372 |
| Accounts receivable | -7,874 | -12,781 | -4,524 | -16,303 | -2,978 |
| Accounts payable and accrued liabilities | -374 | -272 | -658 | 3,066 | 3,874 |
| Other Working Capital | -45,924 | -48,308 | -9,791 | -7,239 | -23,427 |
| Other Operating Activity | 45,992 | 49,251 | 18,313 | 69,714 | 34,771 |
| Operating Cash Flow | $-23,495 | $-34,602 | $-4,431 | $21,060 | $-3,958 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 114,031 | 92,675 | 32,445 | -472,415 | -96,201 |
| PPE Investments | -17,589 | -11,542 | -4,716 | -40,002 | -36,224 |
| Net Acquisitions | 3,775 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 454,065 | 101,528 |
| Investing Cash Flow | $100,217 | $81,133 | $27,729 | $-58,352 | $-30,897 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -782 | -694 | -606 | -1,774 | -1,638 |
| Common Stock Issued | N/A | N/A | N/A | 51 | N/A |
| Common Stock Repurchased | -13,473 | -13,116 | -10,566 | -3,124 | -2,882 |
| Financing Cash Flow | $-14,255 | $-13,810 | $-11,172 | $-4,847 | $-4,520 |
| Exchange Rate Effect | 30 | 15 | 11 | -55 | 79 |
| Beginning Cash Position | 55,279 | 55,279 | 55,279 | 97,473 | 97,473 |
| End Cash Position | 117,776 | 88,015 | 67,416 | 55,279 | 58,177 |
| Net Cash Flow | $62,497 | $32,736 | $12,137 | $-42,194 | $-39,296 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,495 | -34,602 | -4,431 | 21,060 | -3,958 |
| Capital Expenditure | -17,594 | -11,544 | -4,718 | -40,315 | -36,537 |
| Free Cash Flow | -41,089 | -46,146 | -9,149 | -19,255 | -40,495 |